Halma plc 4.1% Potential Decrease Indicated by Barclays Capital

Broker Ratings

Halma plc with EPIC/TICKER (LON:HLMA) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘EQUAL WEIGHT’ this morning by analysts at Barclays Capital. Halma plc are listed in the Industrials sector within UK Main Market. Barclays Capital have set a target price of 2140 GBX on its stock. This now indicates the analyst believes there is a potential downside of -4.1% from today’s opening price of 2231 GBX. Over the last 30 and 90 trading days the company share price has decreased 20 points and increased 197 points respectively. The 52 week high share price is 2377 GBX while the year low stock price is currently 1660 GBX.

Halma plc has a 50 day moving average of 2,291.06 GBX and a 200 Day Moving Average share price is recorded at 2,115.67. There are currently 349,281,622 shares in issue with the average daily volume traded being 984,169. Market capitalisation for LON:HLMA is £8,753,102,407 GBP.

Share on:
Find more news, interviews, share price & company profile here for:
    Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy.
    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.
    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.

      Search

      Search